Vogl, Thomas

Publishing since 1983 (Dinosaur)

Has published 86 publications in 28 years

Number of publications published per year by Vogl, Thomas. (Source : PubMed)

Distribution of publications types for Vogl, Thomas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Albert JG, Vogl T, Zeuzem S, Bojunga J. Use of Computed Tomography with Reformatted Imaging to Identify Ingested Drug Packets.  Clin. Gastroenterol. Hepatol.  2010  
•  Schaudt A, Kriener S, Schwarz W, Wullstein C, Zangos S, Vogl T, Mehrabi A, Fonouni H, Bechstein WO, Golling M. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.  Clin Transplant  2009;23 Suppl 21  
•  Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, Tartaglia GG, Vogl T, Kayed R, Wingsle G, Olsson J, Dobson CM, Bergh A, Elgh F, Morozova-Roche LA. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate.  PLoS ONE  2009;4;5  
•  Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, Varki N, Kronenberg M, Freeze HH, Srikrishna G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.  Carcinogenesis  2008;29;10  
•  Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.  J. Exp. Med.  2008;205;10  
•  Moench C, Burck I, Bug R, Bak YJ, Richter B, Schroeder R, Klarner A, Strey CW, Vogl T, Bechstein W. [Hepatic angiomyolipoma--a rare liver tumor]  Z Gastroenterol  2008;46;1  
•  Baghi M, Mack MG, Wagenblast J, Hambek M, Rieger J, Bisdas S, Gstoettner W, Engels K, Vogl T, Knecht R. Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?  Anticancer Res.  2007;27;5B  
•  Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.  Nat. Med.  2007;13;9  
•  Viemann D, Barczyk K, Vogl T, Fischer U, Sunderkötter C, Schulze-Osthoff K, Roth J. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program.  Blood  2007;109;6  
•  Vogl T, Eichler K, Zangos S, Herzog C, Hammerstingl R, Balzer J, Gholami A. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.  J. Cancer Res. Clin. Oncol.  2007;133;3  

[ See timeline ] [ See all publications ]